Last updated: November 9, 2023
Sponsor: Hospices Civils de Lyon
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Inflammation
Ulcerative Colitis (Pediatric)
Treatment
pro-inflammatory cytokines
Clinical Study ID
NCT05944822
69HCL23_0557
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- women over 18
- intervention between January 2021 and November 2022
- person having expressed his non-opposition Essure group : patient who underwent removal of the Essure® contraceptive implant Control with no endometriosis/adenomyosis : patient who underwent benign laparoscopicgynecological surgery and with no diagnosis of endometriosis or adenomyosis Control with endometriosis/adenomyosis : patient who underwent benign laparoscopicgynecological surgery and with diagnosis of endometriosis or adenomyosis
Exclusion
Exclusion Criteria:
- inability to understand the information given
- person deprived of liberty
- person under guardianship
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: pro-inflammatory cytokines
Phase:
Study Start date:
November 01, 2022
Estimated Completion Date:
December 30, 2023
Connect with a study center
Gynaecology Department, Hôpital Femme Mère Enfant Hospices Civisl de Lyon
Bron, 69500
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.